Carregant...
Sustainable therapies by engineered bacteria
The controlled in situ delivery of biologics (e.g. enzymes, cytokines, antibodies) by engineered bacteria of our microbiome will allow the sustainable production of these complex and expensive drugs locally in the human body, overcoming many of the technical and economical barriers currently associa...
Guardat en:
| Publicat a: | Microb Biotechnol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5609241/ https://ncbi.nlm.nih.gov/pubmed/28696008 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1751-7915.12778 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|